Angiogenesis inhibitors in the treatment of colorectal cancerIQBAL, Syma; LENZ, Heinz-Josef.Seminars in oncology. 2004, Vol 31, Num 6, pp 10-16, issn 0093-7754, 7 p., SUP17Article

Angiogenesis as a target in colorectal cancer therapyLENZ, Heinz-Josef.Seminars in oncology. 2004, Vol 31, Num 6, issn 0093-7754, 33 p., SUP17Serial Issue

EGFR Signaling and Drug DiscoveryLURJE, Georg; LENZ, Heinz-Josef.Oncology. 2009, Vol 77, Num 6, pp 400-410, issn 0030-2414, 11 p.Article

Molecular Pathways: Turning Proteasomal Protein Degradation into a Unique Treatment ApproachSTINTZING, Sebastian; LENZ, Heinz-Josef.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3064-3070, issn 1078-0432, 7 p.Article

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!STINTZING, Sebastian; LENZ, Heinz-Josef.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 16, pp 2203-2220, issn 1465-6566, 18 p.Article

Targeted therapy and pharmacogenomic programsIQBAL, Syma; LENZ, Heinz Josef.Cancer. 2003, Vol 97, Num 8, pp 2076-2082, issn 0008-543X, 7 p., SUPConference Paper

Cyclooxygenase-2 inhibitors in colorectal cancerSTOEHLMACHER, Jan; LENZ, Heinz-Josef.Seminars in oncology. 2003, Vol 30, Num 3, pp 10-16, issn 0093-7754, 7 p., SUP6Article

Future directions in the use of antiangiogenic agents in patients with colorectal cancerHOFF, Paulo M.Seminars in oncology. 2004, Vol 31, Num 6, pp 17-21, issn 0093-7754, 5 p., SUP17Article

Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodiesWU ZHANG; GORDON, Michael; LENZ, Heinz-Josef et al.Annals of medicine (Helsinki). 2006, Vol 38, Num 8, pp 545-551, issn 0785-3890, 7 p.Article

EGFR, HER2 and VEGF pathways : Validated targets for cancer treatmentPRESS, Michael F; LENZ, Heinz-Josef.Drugs (Basel). 2007, Vol 67, Num 14, pp 2045-2075, issn 0012-6667, 31 p.Article

The role of proteasome inhibitors in solid tumors : Proteasome inhibitionPARK, David J; LENZ, Heinz-Josef.Annals of medicine (Helsinki). 2004, Vol 36, Num 4, pp 296-303, issn 0785-3890, 8 p.Article

Angiogenesis and its role in colorectal tumor and metastasis formationELLIS, Lee M.Seminars in oncology. 2004, Vol 31, Num 6, pp 3-9, issn 0093-7754, 7 p., SUP17Article

Pharmacogenomics in colorectal cancerLENZ, Heinz Josef.Seminars in oncology. 2003, Vol 30, Num 4, pp 47-53, issn 0093-7754, 7 p., SUP15Article

Panitumumab safety for treating colorectal cancerSTREMITZER, Stefan; SEBIO, Ana; STINTZING, Sebastian et al.Expert opinion on drug safety. 2014, Vol 13, Num 6, pp 843-851, issn 1474-0338, 9 p.Article

Predictive Molecular Classifiers in Colorectal Cancer : COLORECTAL CANCERBOHANES, Pierre; LABONTE, Melissa J; WINDER, Thomas et al.Seminars in oncology. 2011, Vol 38, Num 4, pp 576-587, issn 0093-7754, 12 p.Article

Assessing the in vivo efficacy of biologic antiangiogenic therapiesWILSON, Peter M; LABONTE, Melissa J; LENZ, Heinz-Josef et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 1-12, issn 0344-5704, 12 p.Article

Markers of Response for the Antiangiogenic Agent BevacizumabLAMBRECHTS, Diether; LENZ, Heinz-Josef; DE HAAS, Sanne et al.Journal of clinical oncology. 2013, Vol 31, Num 9, pp 1219-1230, issn 0732-183X, 12 p.Article

Safety and pharmacokinetics of the dual action raf kinase and vascular endothelial growth factor receptor inhibitor, bay 43-9006, in patients with advanced, refractory solid tumorsCLARK, Jeffrey W; EDER, Joseph P; RYAN, David et al.Clinical cancer research. 2005, Vol 11, Num 15, pp 5472-5480, issn 1078-0432, 9 p.Article

The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinomaSTOEHLMACHER, Jan; INGLES, Sue A; PARK, David J et al.Oncology reports. 2002, Vol 9, Num 2, pp 235-238, issn 1021-335XArticle

Molecular Pathways: Estrogen Pathway in Colorectal CancerBARZI, Afsaneh; LENZ, Annika Medea; LABONTE, Melissa J et al.Clinical cancer research (Print). 2013, Vol 19, Num 21, pp 5842-5848, issn 1078-0432, 7 p.Article

Pharmacogenomics and metastatic colorectal cancer: Current knowledge and perspectivesBENHAIM, Leonor; LABONTE, Melissa Janae; LENZ, Heinz-Josef et al.Scandinavian journal of gastroenterology. 2012, Vol 47, Num 3, pp 325-339, issn 0036-5521, 15 p.Article

Pharmacogenomics and -genetics in colorectal cancerPOHL, Alexandra; LURJE, Georg; MANEGOLD, Philipp C et al.Advanced drug delivery reviews. 2009, Vol 61, Num 5, pp 375-380, issn 0169-409X, 6 p.Article

Pancreatic Cancer: Medical Management (Novel Chemotherapeutics)PAEZ, David; LABONTE, Melissa J; LENZ, Heinz-Josef et al.Gastroenterology clinics of North America. 2012, Vol 41, Num 1, issn 0889-8553, x, 189-209 [22 p.]Article

Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cellsFAZZONE, William; WILSON, Peter M; LABONTE, Melissa J et al.International journal of cancer (Print). 2009, Vol 125, Num 2, pp 463-473, issn 0020-7136, 11 p.Article

Colorectal cancerCUNNINGHAM, David; ATKIN, Wendy; LENZ, Heinz-Josef et al.Lancet (British edition). 2010, Vol 375, Num 9719, pp 1030-1047, issn 0140-6736, 18 p.Article